Kolon TissueGene코오롱티슈진
950160 · KOSDAQ · ₩950160 · 코오롱티슈진
₩14,300▼ ₩300 (2.05%)End-of-day · Oct 29, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 12.8% | 13.3% | 11.7% | 11.1% | 81.3% | 10.9% |
| Operating margin | −499.7% | −432.7% | −433.6% | −553.3% | −172.4% | −1,171.7% |
| Net margin | −1,863.5% | −3,733.3% | −666.2% | −464.8% | −117.8% | −1,183.3% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | −8.6% | −2.5% | +31.0% | −61.2% | +109.2% | — |
| Operating income growth | −5.5% | +2.7% | −2.7% | −24.5% | +69.2% | — |
| Net income growth | +54.4% | −446.5% | −87.8% | −53.1% | +79.2% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | −69.8% | −188.2% | −26.3% | −16.4% | −16.5% | −127.0% |
| Return on assets | −19.7% | −60.6% | −19.4% | −13.8% | −12.4% | −79.9% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 151.4% | 561.6% | 52.4% | 17.4% | 20.1% | 58.9% |
| Net debt to equity | −18.5% | −12.3% | 6.9% | — | −44.9% | −100.4% |
| Current ratio | 33.2% | 24.3% | 10.4% | 223.9% | 543.5% | 269.2% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Kolon TissueGene / 코오롱티슈진 / 950160 / KRX:950160
Source: KRX statistical information